Sandbox Myopathy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
{| class="wikitable"
{| class="wikitable"
! rowspan="3" |Disease
! rowspan="3" |Disease
! colspan="9" |Symptoms
! colspan="10" |Symptoms
! rowspan="3" |History
! rowspan="3" |History
! rowspan="3" |Physical
! rowspan="3" |Physical
Line 13: Line 13:
|-
|-
! rowspan="2" |Age of onset
! rowspan="2" |Age of onset
! rowspan="2" |Site of muscle weakness
! colspan="2" |Muscle weakness
! colspan="2" |Muscle weakness
! rowspan="2" |Fever
! rowspan="2" |Fever
Line 28: Line 29:
!DIstal
!DIstal
|-
|-
! colspan="17" |Medications
! colspan="18" |Medications
|-
|-
|Corticosteroids
|Corticosteroids
|Variable
|Variable
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 61: Line 63:
|Statins
|Statins
|60+
|60+
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 87: Line 90:
|Alcohol
|Alcohol
|Variable
|Variable
|
|      '''+'''
|      '''+'''
|
|
Line 106: Line 110:
|
|
|-
|-
! colspan="17" |Endocrine  
! colspan="18" |Endocrine  
|-
|-
|Cushing's disease
|Cushing's disease
|25 -45  
|25 -45  
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 146: Line 151:
|-
|-
|Adrenal insufficiency
|Adrenal insufficiency
|
|
|
|
|
Line 164: Line 170:
|-
|-
|Secondary hyperparathyroidism
|Secondary hyperparathyroidism
|
|
|
|
|
Line 182: Line 189:
|-
|-
|Hyperthyroidism
|Hyperthyroidism
|
|
|
|
|
Line 200: Line 208:
|-
|-
|Hypothyroidism
|Hypothyroidism
|
|
|
|
|
Line 217: Line 226:
|
|
|-
|-
! colspan="17" |Inflammatory / Rheumatologic  
! colspan="18" |Inflammatory / Rheumatologic  
|-
|-
|Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
|Dermatomyositis<ref name="pmid1658649">{{cite journal| author=Dalakas MC| title=Polymyositis, dermatomyositis and inclusion-body myositis. | journal=N Engl J Med | year= 1991 | volume= 325 | issue= 21 | pages= 1487-98 | pmid=1658649 | doi=10.1056/NEJM199111213252107 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1658649  }}</ref>
Line 223: Line 232:
* 40s-50s
* 40s-50s
* Can affect childreen  
* Can affect childreen  
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| -
| -
Line 253: Line 263:
|
|
* > 18 years  
* > 18 years  
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| -
| -
Line 274: Line 285:
|
|
* 50s  
* 50s  
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| +
| +
Line 293: Line 305:
|
|
* 40-50s  
* 40-50s  
|
|
|
+
+
Line 323: Line 336:
|
|
* 50s
* 50s
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 346: Line 360:
* Normal  
* Normal  
|-
|-
! colspan="17" |Genetic
! colspan="18" |Genetic
|-
|-
|Becker muscular dystrophy
|Becker muscular dystrophy
|<13yrs
|<13yrs
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 374: Line 389:
|Duchenne muscular dystrophy
|Duchenne muscular dystrophy
|<13 yrs
|<13 yrs
|
| +
| +
| -
| -
Line 400: Line 416:
|Limb-girdle muscular dystrophies
|Limb-girdle muscular dystrophies
|<15 yrs
|<15 yrs
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 429: Line 446:
|-
|-
|Myotonic dystrophy type 1
|Myotonic dystrophy type 1
|
|
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 454: Line 472:
|
|
|-
|-
! colspan="17" |Infectious
! colspan="18" |Infectious
|-
|-
|Lyme disease
|Lyme disease
|Variable
|Variable
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 488: Line 507:
|Infulenza
|Infulenza
|Variable
|Variable
|
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 516: Line 536:
|Polio
|Polio
|<5 yrs
|<5 yrs
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 546: Line 567:
|Syphilis
|Syphilis
|Variable
|Variable
|
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 579: Line 601:
|Pyomyositis
|Pyomyositis
|Variable
|Variable
|
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
Line 605: Line 628:
* -
* -
|-
|-
! colspan="17" |Neurologic
! colspan="18" |Neurologic
|-
|-
|ALS
|ALS
|
|
|
|
|
Line 626: Line 650:
|-
|-
|Stroke
|Stroke
|
|
|
|
|
Line 644: Line 669:
|-
|-
|GBS
|GBS
|
|
|
|
|
Line 662: Line 688:
|-
|-
|Multiple Sclerosis
|Multiple Sclerosis
|
|
|
|
|
Line 679: Line 706:
|
|
|-
|-
! colspan="17" |Neuro-muscular  
! colspan="18" |Neuro-muscular  
|-
|-
|Botulisim
|Botulisim
|
|
|
|
|
Line 700: Line 728:
|-
|-
|Lambert-Eaton myaes
|Lambert-Eaton myaes
|
|
|
|
|
Line 718: Line 747:
|-
|-
|Myasthenia gravis
|Myasthenia gravis
|
|
|
|
|
Line 735: Line 765:
|
|
|-
|-
! colspan="17" |Paraneoplastic
! colspan="18" |Paraneoplastic
|-
|-
|
|
|
|
|
Line 755: Line 786:
|
|
|-
|-
! colspan="17" |Metabolic
! colspan="18" |Metabolic
|-
|-
|Glycogen storage disease
|Glycogen storage disease
|
|
|
|
|
Line 776: Line 808:
|-
|-
|Lipid storage disease
|Lipid storage disease
|
|
|
|
|
Line 794: Line 827:
|-
|-
|Mitochondrial
|Mitochondrial
|
|
|
|
|

Revision as of 18:28, 3 April 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Differentiating Various Muscle Weakness

Disease Symptoms History Physical

Examination

Diagnosis
Age of onset Site of muscle weakness Muscle weakness Fever Muscle pain Gait abnormality Neuropathy Myoglobinuria Other features Laboratory Findings Creatine Kinase Muscle Biopsy Electromyogram
Proximal DIstal
Medications
Corticosteroids Variable + - - + - - -
  • + History of medications
  • Facial and sphincter muscles usually are spared
- - -
Statins 60+ + - - + - - -/+(rhabdomyolysis)
  • N/A
  • Positive medication history
  • Tenderness
  • Muscle aches
  • ↑↑ liver enzymes
  • ↑↑
  • Necrosis
  • Degeneration, and regeneration of fibers
  • Phagocytic infiltration
-
Alcohol Variable + +
  • Change in mental status
  • Telangiectasia
  • Peripheral neuropathy
Endocrine
Cushing's disease 25 -45 + - - - - - -
  • Decreased libido
  • Obesity/weight gain
  • Plethora
  • Round face
  • Menstrual changes
  • Hirsutism
  • Hypertension
  • Ecchymoses
  • Lethargy, depression
  • Dorsal fat pad
  • Abnormal glucose tolerance
  • Facial and sphincter muscles usually are spared
  • Overweight
  • Straie
  • Moon face
  • HTN
  • Hyperpigmentation
- - -
Adrenal insufficiency -
Secondary hyperparathyroidism
Hyperthyroidism
Hypothyroidism
Inflammatory / Rheumatologic
Dermatomyositis[1]
  • 40s-50s
  • Can affect childreen
+ - + + - - -
  • Rash
  • Dyspnea
  • Weight loss
  • Cough
  • Heliotrope rash on face and hands
  • Telangectasia
  • Erythema
  • Mechanic's hands
  • Gottron's sign ( violaceous scaly eruption )
  • ↑↑
  • Perimysial mononuclear infiltrate
  • Muscle inflammation and damage
Polymyositis[2]
  • > 18 years
+ - + + - - - - -
  • ↑↑
  • Endomysial mononuclear infiltrate
  • Patchy necrosis
Inclusion body myositis[3]
  • 50s
+ +
  • ↑↑
Fibomyalgia
  • 40-50s

+

- - - - ++ -
  • Anxiety or depression features
  • Fatigue
  • Sleep disturbance
  • Numbness
  • Muscle spasms
  • History of depressive disorder
  • Tenderness in the soft tissue anatomical location
  • Normal
  • Normal
  • Normal
  • Normal
Polymyalgia Rheumatica[4]
  • 50s
+ - + + - - -
  • Weight loss
  • History of joints stiffness which is worse in the morning
  • Restricted shoulder motion
  • ↑ CRP
  • ↑ ESR
  • Normal
  • Normal
  • Normal
Genetic
Becker muscular dystrophy <13yrs + - - - + - -
  • Milder form of Duchenne
  • ↑↑
    • Muscle fibril degeneration, regeneration
    • Isolated fiber hypertrophy
    • Muscle replacement with fat and connective tissue
  • Weakness is caused by destruction of muscle.
Duchenne muscular dystrophy <13 yrs + - - - + - -
  • Calf psedohypertrophy
  • Cardiomyopathy
  • Kyphoscoliosis
  • Cognitive impairment
  • +Grower sign
  • ↑↑
Limb-girdle muscular dystrophies <15 yrs + - - + + - -
  • Calf hypertrophy
  • Scapular winging
  • Cardiomyopathy
  • Cardiac arrhythmias
  • Respiratory muscle weakness
  • Autosomal dominant
  • LMNA gene
  • CAV3 gene
  • ↑↑
  • -
Myotonic dystrophy type 1 + + - - + - -
  • Myotonia
  • Cataracts
  • Diabetes mellitus
  • Frontal balding
  • Cardiac arrhythmias
  • Cholecystitis
  • Pregnancy
  • Eyelid ptosis
Infectious
Lyme disease Variable + - + + +/- + -
  • + Tick bite
  • Hiking/Tip
  • Clinical diagnosis
  • +Serology
  • -
  • -
  • -
Infulenza Variable - - + + + - +
  • Fever
  • Malaise
  • Rhinorrhea
  • Muscle pain worse with movement
  • Muscle weakness, tenderness, and swelling.
  • ↑↑ Liver enzymes
  • +PCR
  • ↑↑
  • -
  • -
Polio <5 yrs + - - - + + -
  • Isolation from pharyngealsecretions, CSF
  • +Serology
  • -
  • -
  • Neurological pattern
Syphilis Variable - - - - + + -
  • Chancre
  • Lymphadenopathy
  • Condylomata lata
  • Neuro syphilis
  • Cardiovascular syphilis
  • History of risk factors (MSM, unprotected sex, multiple sex partners)
  • Darkfield examinations
  • VDRL
  • RPR
  • FTA-ABS
  • -
  • -
  • -
Pyomyositis Variable +/- +/- + + - - -
  • Fever
  • Malaise
  • Psoas abscess
  • Immunocopmprimised
    • Muscles are painful, swollen, tender, and indurated.
    • Depending on the site of involvement, it may mimic appendicitis (psoas muscle), septic arthritis of the hip (iliacus muscle), or epidural abscess (piriformis muscle).
  • Leukocytosis
  • Elevated ESR
  • -
  • -
  • -
Neurologic
ALS
Stroke
GBS
Multiple Sclerosis
Neuro-muscular
Botulisim
Lambert-Eaton myaes
Myasthenia gravis
Paraneoplastic
Metabolic
Glycogen storage disease
Lipid storage disease
Mitochondrial
  1. Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
  2. Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
  3. Dalakas MC (1991). "Polymyositis, dermatomyositis and inclusion-body myositis". N Engl J Med. 325 (21): 1487–98. doi:10.1056/NEJM199111213252107. PMID 1658649.
  4. Myklebust G, Gran JT (1996). "A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis". Br J Rheumatol. 35 (11): 1161–8. PMID 8948307.